Cannasouth

Cannasouth is a biopharmaceutical research and development company based in Waikato, New Zealand. The company has been established to focus on the commercial development of the medicinally beneficial attributes of cannabinoid compounds such as CBD, THC and associated chemical structures that are produced by the cannabis plant. The goal is the development of next-generation cannabinoid medicines that support patients' health outcomes and improve quality of life. Cannasouth products will be produced under GMP & ISO using environmentally friendly methods without the use of harmful chemicals or solvents, ensuring patients are treated with pure cannabinoid therapeutic compounds of the highest quality.


Company Details

Registered Office: CRV Building, Level 2, Waikato Innovation Park, 2 Melody Lane, Hamilton East, Hamilton, 3216
Postal Address: CRV Building, Level 2, Waikato Innovation Park, 2 Melody Lane, Hamilton East, Hamilton, 3216
Telephone: +64-7-949-8393
Facsimile: n/a
Website: https://cannasouth.co.nz/
First Listed: 19/06/2019
Balance Date: 31 December
AGM: 30/06/2023

Directors and Executives

Colin Foster
CFO / Company Secretary
Anthony Ho
Independent Chairman
Mark Lucas
Chief Executive Officer
Christine Pears
Independent Non-Executive Director
Mark Scapens
Non-Executive Director

Announcements


Major Holdings Announcements

Date Name No. Held % Current
15/08/23 Nicholas Jon Foreman 23,605,360 17.61 7.36
26/06/23 Mark James Scapens 23,887,591 - 7.45
08/06/23 Mark Lucas 28,029,435 27.60 8.74
11/03/20 Adam Sorensen 5,165,563 6.14 4.89

Director’s Interests Announcements

Date Name No. Held % Details Other
13/02/24 Anthony Ho 2,700,000 - - -
19/12/23 Christine Pears 210,000 - - -
22/06/23 Gregory Misson 1,136,067 - - -
08/06/23 Hilary Webber. 2,710,425 - - -
15/09/22 Juliet Hull 28,766 - - -
10/08/21 Colin Foster 250,000 - - -
23/10/20 Conor English 4,741 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 13/02/2024


Markets News

NZ sharemarket favours OCR cut, up 1.75%
Markets Market close

NZ sharemarket favours OCR cut, up 1.75%

The S&P/NZX 50 Index closed at 12,776.13, up 220.14 points or 1.75%.

Graham Skellern 09 Oct 2024
Economy

Fast-track projects could inject energy into economy

A construction boost and lower interest rates could kickstart flagging activity.

Ian Llewellyn 09 Oct 2024
Fast-track projects could inject energy into economy
Markets

Vista board battle stokes 'culture clash' fears

PE firm's hardball play to roll chair may galvanise opposition to its board quest.

Vista board battle stokes 'culture clash' fears
Markets Market close

NZ sharemarket slides despite some positive data

The S&P/NZX 50 Index closed at 12,555.99, down 40.88 points or 0.33%.

Graham Skellern 08 Oct 2024
NZ sharemarket slides despite some positive data
Markets

Lake Pūkaki returns to average levels

It reduces some of the pressure around energy supply in winter 2025.

Ian Llewellyn 08 Oct 2024
Lake Pūkaki returns to average levels